Protein Biomarkers in Major Depressive Disorder: An Update (Q92193007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

title

Protein Biomarkers in Major Depressive Disorder: An Update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

major depressive disorder

1 reference

Alisa G Woods

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

Kelly L Wormwood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

Dan V Iosifescu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

James Murrough

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

Costel C Darie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

Advances in Experimental Medicine and Biology

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

volume

1140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

585-600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

27 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Depression and heart disease in US adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Prevalence of depression in consecutive patients with type 2 diabetes mellitus of 5-year duration and its impact on glycemic control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Cost of lost productive work time among US workers with depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Medication augmentation after the failure of SSRIs for depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Allosteric modulators of α4β2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biomarker-Based Selection of Therapy For Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biomarkers in psychiatry: drawbacks and potential for misuse

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biomarkers in psychiatry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Potential biomarkers in psychiatry: focus on the cholesterol system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) tr

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Electroencephalography-derived biomarkers of antidepressant response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The genetics of bipolar disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Gene-environment interaction and suicidal behavior.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

A mega-analysis of genome-wide association studies for major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

A comparison of selected mRNA and protein abundances in human liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Proteomic approach for the elucidation of biological defects in autism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Mass spectrometry for the detection of potential psychiatric biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Mass spectrometry as a tool for studying autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biomarkers in major depressive disorder: the role of mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Deafferentation-induced increases in hippocampal insulin-like growth factor-1 messenger RNA expression are severely attenuated in middle aged and aged rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Novel biomarkers in major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Neurogenesis and major depression: implications from proteomic analyses of hippocampal proteins in a rat depression model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

High-dimensional mapping of the hippocampus in depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Protein and peptide profiling as a tool for biomarker discovery in depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Evaluation of a novel ELISA for serotonin: urinary serotonin as a potential biomarker for depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Human saliva proteome and transcriptome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

A two-year follow-up study of salivary cortisol concentration and the risk of depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The carboxyl-terminal domains of IgA and IgM direct isotype-specific polymerization and interaction with the polymeric immunoglobulin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The function of immunoglobulin A in immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The lipocalin protein family: structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Biochemistry of human alpha amylase isoenzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

The structure and function of proline-rich regions in proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Identification of TOSO/FAIM3 as an Fc receptor for IgM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Human lactotransferrin: molecular, functional and evolutionary comparisons with human serum transferrin and hen ovotransferrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser desorption/ionization-time of flight

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Plasma Metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-15950-4_35

Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012

31 March 2020

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.15585/MMWR.SS6513A1

Identifiers

DOI

10.1007/978-3-030-15950-4_35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31347073 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference